Global contract packaging organization (CPO), Tjoapack has launched a new postponement packaging service to help customers address supply chain challenges including variable demand and repackaging work.
Postponement packaging is the practice of keeping products market agnostic for as long as possible, only adding the relevant language leaflets and meeting the local legislation requirements when there is market demand.
The new service follows an investment into its late stage customization printing capabilities earlier this year.
“Postponement packaging can offer customers more control over their supply chains. By giving them the flexibility to adapt to market related variations and avoid repackaging work, it is possible to lower working capital and reduce finished goods inventories. All of which can ultimately help to offset the rising cost of healthcare,” Eric Tjoa, founder of Tjoapack said. “Although the concept is not yet widely adopted in the pharmaceutical sector, it has been proven in other industries, such as automotive and cosmetics, and can bring huge benefits to the supply chain.”
The first phase of the new postponement service will be fully operational by the end of Q3 2018.
Tjoapack will be hosting an event at its facility in Etten-Leur, the Netherlands, on November 22, 2018 to discuss its capabilities and the benefits a postponement strategy can bring to the pharmaceutical industry.
Founded in 1989, Tjoapack is an independent contract packager of medicines servicing clients across five continents and 42 countries.
The CPO specializes in primary packaging for solid dosage forms, secondary packaging and unit dose packaging and now has a total of 19 packaging lines for blisters, wallets and bottles. Using these lines, it packages around 26 million packs of pharmaceutical products per year, which equates to around 1.4 billion tablets.